Molecular characterization of extended-spectrum beta-lactamase-producing Enterobacterales isolates collected from blood culture in patients with hematological malignancies | CMAC

Molecular characterization of extended-spectrum beta-lactamase-producing Enterobacterales isolates collected from blood culture in patients with hematological malignancies

Clinical Microbiology and Antimicrobial Chemotherapy. 2018; 20(4):375-380

​ Khrulnova S.A., Korobova A.G., Fyodorova A.V., Frolova I.N., Klyasova G.A.
10.36488/cmac.2018.4.375-380
Enterobacterales ESBL blood culture beta-lactamase genes hematological malignancies
Section
Antimicrobial Resistance
Type
Journal article
Publication
Clinical Microbiology and Antimicrobial Chemotherapy. 2018; 20(4):375-380

Objective.

The objective of the study was to evaluate the prevalance of genes blaTEM, blaSHV and blaCTX-M among extended-spectrum beta-lactamase (ESBL)-producing Enterobacterales isolates collected from blood culture in patients with hematological malignancies.

Materials and methods.

The prospective multicenter study included Enterobacterales isolates collected from blood culture in hematological patients from 10 Russian hospitals (2003-2015). The isolates were screened for ESBLs by the phenotypic methods (CLSI 2017). Genes encoding TEM, SHV and CTX-M were detected using polymerase chain reaction (PCR) by specific primers.

Results.

A total of 499 ESBL-producing Enterobacterales were evaluated. Among them Klebsiella pneumoniae (43.9%) and Escherichia coli (43.3%) predominated. The tested genes were present in combination (79%) and alone (19.6%). Genes of blaCTX-M were most common (82.6%), followed by blaTEM (73.7%) and blaSHV (53.7%). The genes (blaTEM, blaSHV and blaCTX-M) were not detected in 1.4% (n=7) ESBLproducing Enterobacterales. Genes blaCTX-M were in 84.9% K. pneumoniae, 89.8% E. coli and 42.6% Enterobacter cloacae. The blaCTX-M genes belonged to the subtypes blaCTX-M-1 (88.8%), blaCTX-M-9 (14.8%) and blaCTX-M-2 (0.2%). Two different subtypes of blaCTX-M were in 4.1% Enterobacterales isolates.

Conclusions.

Among the ESBL-producing Enterobacterales isolates blaCTX-M genes were most common (82.6%), the majority of them belonged to the blaCTX-M-1 subtypes (88.8%). Most of Enterobacterales isolates (79%) harbored several types of beta-lactamases genes and 4.1% isolates carried two subtypes of blaCTX-M.

Svetlana A. Khrulnova

National Medical Research Center of Hematology, Moscow, Russia

Korobova A.G.

National Medical Research Center of Hematology, Moscow, Russia

Anastasiya V. Fyodorova

National Medical Research Center of Hematology, Moscow, Russia

Frolova I.N.

National Medical Research Center of Hematology, Moscow, Russia

Galina A. Klyasova

National Medical Research Center of Hematology, Moscow, Russia

  • 1. Klyasova G.А., Speranskaya L.L., Mironova А.V., et al. The pathogens causing sepsis in immunocompromized patients: structure and problems of antibiotic resistance. Results of a multi-center cooperative study. Gemаtologiya i trаnsfuziologiya. 2007;52(1):13-18. Russian.
  • 2. Sidorenko S.V., Stratchounski L.S., Ahmedova L.I., et al. The results of the multicenter study of the comparative activity of cefepime and other antibiotics against pathogens of severe nosocomial infection (the program "Micromax"). Аntibiotiki i khimioterapiya. 1999;44(11):716. Russian.
  • 3. Eidelstein M., Pimkin M., Palagin I., Eidelstein I., Stratchounski L. Prevalence and molecular epidemiology of CTX-M extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae in Russian hospitals. Antimicrob Agents Chemother. 2003;47:37243732.
  • 4. Eidelstein M.V, Strachounski L.S. Trends in the prevalence and susceptibility of ESBL-producing Entererobacteriaceae to various antimicrobial agents in Russian ICUs. Klinicheskaya mikrobiologiya antimikrobnaya khimioterapiya. 2005;7(4):323-336. Russian.
  • 5. Klyasova G.А. Okhmat V.А. Antimicrobial therapy. In: Savchenko V.G., ed. Algorithms of diagnosing and protocols of treatment of blood system diseases. Moscow: Praktika; 2018. P.1069-1113. Russian.
  • 6. Payne D.J., Marriott M.S., Amyes S.G. Characterization of a unique ceftazidime-hydrolysing beta-lactamase, TEM-E2. J Med Microbiol. 1990;32(2):131-134.
  • 7. Heritage J., Hawkey P.M., Todd N., Lewis I.J. Transposition of the gene encoding a TEM-12 extended-spectrum beta-lactamase. Antimicrob Agents Chemother. 1992;36(9):1981-1986.
  • 8. Knothe H., Shah P., Krcmery V., Antal M., Mitsuhashi S. Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens. Infection. 1983;11(6):315-317.
  • 9. Kliebe C., Nies B.A., Meyer J.F., Tolxdorff-Neutzling R.M., Wiedemann B. Evolution of plasmid-coded resistance to broad-spectrum cephalosporins. Antimicrob Agents Chemother. 1985;28(2):302-307.
  • 10. Bauernfeind A., Schweighart S., Grimm H. A new plasmidic cefotaximase in a clinical isolate of Escherichia coli. Infection. 1990;18(5):294-298.
  • 11. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing; Twenty-Seventh Informational Supplement. CLSI document M100-S27. Wayne, PA: Clinical and Laboratory Standards Institute; 2017.
  • 12. Woodford N., Fagan E.J., Ellington M.J. Multiplex PCR for rapid detection of genes encoding CTX-M extended-spectrum (beta)lactamases. J Antimicrob Chemother. 2006;57(1):154-155.
  • 13. Pryamchuk S.D., Fursova N.K., Аbaev I.V., et al. Genetic determinants of antibacterial resistance among nosocomial Escherichia coli, Klebsiella spp., and Enterobacter spp. isolates collected in Russia within 2003-2007. Аntibiotiki i khimioterapiya. 2010;55(9-10):310. Russian.
  • 14. Robin F., Beyrouthy R., Bonacorsi S., et al. Inventory of extendedspectrum-β-lactamase-producing Enterobacteriaceae in France as assessed by a multicenter study. Antimicrob Agents Chemother. 2017;61(3):e01911-16.
  • 15. Sidorenko S.V., Berezin А.G., Ivanov D.V. Molecular mechanisms of cephalosporins resistance in gramnegative bacteria of the Enterobacteriaceae family. Аntibiotiki i khimioterapiya. 2004;49(3):616. Russian.
  • 16. Wang S., Zhao S.Y., Xiao S.Z., et al. Antimicrobial resistance and molecular epidemiology of Escherichia coli causing bloodstream infections in three hospitals in Shanghai, China. PLoS One. 2016;11(1):e0147740.
  • 17. Cubero M., Grau I., Tubau F., et al. Molecular Epidemiology of Klebsiella pneumoniae strains causing bloodstream infections in adults. Microb Drug Resist. 2018;24(7):949-957.
  • 18. Denis B., Lafaurie M., Donay J.L., et al. Prevalence, risk factors, and impact on clinical outcome of extended-spectrum beta-lactamaseproducing Escherichia coli bacteraemia: a five-year study. Int J Infect Dis. 2015;39:1-6.
  • 19. Bevan E.R., Jones A.M., Hawkey P.M. Global epidemiology of CTX-M β-lactamases: temporal and geographical shifts in genotype. J Antimicrob Chemother. 2017;72:2145-2155.
  • 20. Arnan M., Gudiol C., Calatayud L., et al. Risk factors for, and clinical relevance of, faecal extended-spectrum β-lactamase producing Escherichia coli (ESBL-EC) carriage in neutropenic patients with haematological malignancies. Eur J Clin Microbiol Infect Dis. 2011;30(3):355-360.
  • 21. Noguchi T., Matsumura Y., Yamamoto M., et al. Clinical and microbiologic characteristics of cefotaxime-non-susceptible Enterobacteriaceae bacteremia: a case control study. BMC Infect Dis. 2017;17(1):44.
  • 22. Shibasaki M., Komatsu M., Sueyoshi N., et al. Community spread of extended-spectrum β-lactamase-producing bacteria detected in social insurance hospitals throughout Japan. J Infect Chemother. 2016;22(6):395-399.
Views
0 Abstract
0 PDF
0 Crossref citations
Shared